Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial
NCT07148206Phase 3Not yet recruiting
- Sponsor
- Montefiore Medical Center
- Start
- Oct 2026
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dronabinol, cannabidiol in opioid use disorder (OUD), sponsored by Montefiore Medical Center. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
dronabinolcannabidiol
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT07148206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07148206.